Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Treatment options for patients with triple-negative breast cancer
10.1186/1756-8722-3-42 · 2010 · External reference
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
10.1200/jco.2011.38.8595 · 2012 · External reference
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 trial—CALGB 150007/150012, ACRIN 6657
10.1200/jco.2011.39.2779 · 2012 · External reference
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
10.1200/jco.2007.14.4147 · 2008 · External reference
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy
10.1186/bcr3197 · 2012 · External reference
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and her-2 is associated with local and distant recurrence after breast-conserving therapy
10.1200/jco.2007.14.4287 · 2008 · External reference
Predictors of locoregional recurrence after neoadjuvant chemotherapy: Results from combined analysis of national surgical adjuvant breast and bowel project b-18 and b-27
10.1200/jco.2011.40.8369 · 2012 · External reference
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy
10.1016/j.ijrobp.2007.01.023 · 2007 · External reference
Increased risk of locoregional recurrence for women with t1-2n0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy
10.1200/jco.2010.33.4714 · 2011 · External reference
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
10.1186/bcr3198 · 2012 · External reference
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
10.1200/jco.2005.02.6914 · 2006 · External reference
Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy
10.1016/j.ijrobp.2010.12.054 · 2012 · External reference
Locoregional recurrence by tumor biology in breast cancer patients after preoperative chemotherapy and breast conservation treatment
10.4143/crt.2015.456 · 2016 · External reference
Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: A prospective randomized controlled multi-center trial
10.1016/j.radonc.2011.07.007 · 2011 · External reference
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy
10.1186/s40064-015-1116-2 · 2015 · External reference
